-
CORRECTING and REPLACING New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology
30 May 2025 19:00 GMT
… with metastatic castration-resistant prostate cancer (mCRPC) with bone … with metastatic castration-resistant prostate cancer (mCRPC) with bone … with metastatic castration-resistant prostate cancer (mCRPC) and bone … risk of cancer and hereditary defects. Due to …
-
ASCO 2025: XOFIGO® (radium-223 dichloride) Combination Data Showcases Clinical Benefits in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
28 May 2025 12:29 GMT
… with metastatic castration-resistant prostate cancer (mCRPC) with … metastatic castration resistant prostate cancer with bone metastases … of cancer and hereditary defects. Due to … in metastatic castration-resistant prostate cancer (mCRPC) starting enzalutamide …
-
Hidden DNA Mutation Raises Prostate Cancer Risk Fivefold – And May Help Target Treatment
23 May 2025 04:48 GMT
… newly identified mutation dramatically raises prostate cancer risk in Ashkenazi Jewish … inhibitors.
A Breakthrough Discovery in Prostate Cancer Genetics
Understanding gene mutations, … and the Patrick C. Walsh Hereditary Prostate Cancer Fund.
Never miss a …
-
Study Suggests Genetic Mutation in Some Ashkenazi Jewish Men May Be Linked to Higher Prostate Cancer Risk
21 May 2025 01:46 GMT
… with (study groups) and without prostate cancer (control groups) — were analyzed, the … an increased likelihood of developing prostate cancer. Likewise, a ratio less than … and the Patrick C. Walsh Hereditary Prostate Cancer Fund.
None of the authors …
-
Research Finds Genetic Mutation in Certain Ashkenazi Jewish Men Associated with Elevated Prostate Cancer Risk
20 May 2025 20:15 GMT
… strong association with prostate cancer risk. Subsequent … genes implicated in hereditary prostate cancer predisposition among … Patrick C. Walsh Hereditary Prostate Cancer Fund, have illuminated … in oncologygenetic mutation prostate cancer riskgenomic integrity …
-
'Possible' to have missed Biden's 'highest-risk' prostate cancer, as routine screening not recommended in older men
20 May 2025 19:45 GMT
… occasionally, where some prostate cancers and some aggressive prostate cancers do not produce … Dr. Leapman said.
What is prostate cancer?
Prostate cancer is a type of cancer … those with a history of hereditary prostate cancer, should avoid getting routine …
-
What Does a Gleason Score of 9 Mean? Understanding Biden’s Prostate Cancer Diagnosis
19 May 2025 08:08 GMT
… has prostate cancer.
Most prostate cancers grow slowly. Those who have genetic or hereditary prostate cancer may … cause prostate cancer cells to grow.
What are the statistics for prostate cancer?
Prostate cancer is …
-
BRCA mutations and prostate cancer: should urologist improve daily clinical practice?
21 Apr 2025 08:34 GMT
To evaluate BRCA1-2 (breast cancer) detection in men with high risk PCa, including the oncological consequences for the patient and family members.
From January 2023 to December 2024, 52 men (median age 73 years;) with confirmed PCa diagnosis underwent …
-
Using Genetic Information to Guide Precision Medicine and Personalized Treatment in Prostate Cancer: Expert Perspectives on an Evolving Landscape
15 Apr 2025 16:20 GMT
Video content above is prompted by the following:
Emerging Genomic Testing Advances: Clinical Implications for the Next 5 Years
Key Projected Developments
Precision Personalized Medicine
Genomic testing is expected to become increasingly sophisticated in …
-
Elevated Expression of STAT6, ERG, and miR-647 Expression as Predictive Biomarkers for Prostate Cancer
10 Apr 2025 13:22 GMT
… with a family history of hereditary diseases.
Immunohistochemistry (IHC)
Briefly, … in patients with prostate cancer (Figure 1). Patients with prostate cancer showed positive … Qi Y, et al. Reshaping prostate tumor microenvironment to suppress metastasis via …
About
© 1995-2025